Nightstar gets rights to Stargardt gene therapy program

The University of Oxford and its research commercialization arm Oxford University Innovation (OUI) granted Nightstar Therapeutics plc (NASDAQ:NITE) exclusive, worldwide rights to the NSR-ABCA4 gene t...